Etiket: Moderna
Vaccine stocks Novavax, BioNTech, Moderna & Co.: Where strong potential lies dormant
shares in this article by Julia Gro, Euro on Sunday Sanofi and GlaxoSmithkline have presented the final data on their protein-based vaccine and announced that they will apply for…
Moderna is working on vaccines for fifteen infectious diseases | Abroad
Drugs in the works against dengue, malaria and Ebola NORWOOD – Biotechnology company Moderna, which has developed an mRNA vaccine against Covid-19, says it is working on 15 more vaccines…
BioNTech shares, Moderna shares & Co: Vaccine shares are looking for the bottom
shares in this article ETFs in this article by Julia Gro, Euro on Sunday M Some analysts want to see a bottoming out in the biotechnology sector. However,…
Moderna: from a mysterious biotech company to a profit of 12 billion dollars
From $747 million loss to $12.2 billion profit a year later. This is only possible if a company sells corona vaccines in a pandemic. The American Moderna announced its quarterly…
Moderna is counting on a turnover of 17 billion euros this year
Biotechnology company Moderna expects to earn more money from its corona vaccine this year than previously reported. The company raised its sales forecast for the vaccine in a trade update…
Moderna wants a branch in the Netherlands | Inland
According to the pharmaceutical company, the local presence of a subsidiary supports the supply of mRNA vaccines and medical treatments in the Netherlands. One of the four pillars is the…
Moderna vaccine gains full approval in US | medical
The corona vaccine from the American pharmaceutical company Moderna has received full approval in the United States for people aged 18 and over. This was reported by the health authorities…
LIVE. Moderna starts clinical trials with vaccine targeting omikron variant
The quarantine rules in education are being relaxed. This was decided by the Interministerial Health Conference last night. For example, classes should no longer close if four students are infected.…
Moderna started testing the Omicron booster
The American company Moderna announced the start of the second phase of clinical trials of a booster vaccine against the omicron strain. The first participant has already been vaccinated. During…
Pfizer and Moderna announced release date for vaccines against omicron – RBK
Pfizer plans to launch a vaccine adapted to the omicron by March, and its production is starting now, said CEO Albert Burla in the air CNBC. “The vaccine will be…